High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old with relapsed or refractory B-cell lymphoma. (Q53570081)
Jump to navigation
Jump to search
scientific article published on 20 February 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old with relapsed or refractory B-cell lymphoma. |
scientific article published on 20 February 2007 |
Statements
High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old with relapsed or refractory B-cell lymphoma. (English)
1 reference
1 reference
1 reference
Frederick R Appelbaum
1 reference
Stephen H Petersdorf
1 reference
David G Maloney
1 reference
Joseph G Rajendran
1 reference
Janet F Eary
1 reference
Ted A Gooley
1 reference
John M Pagel
1 reference
Darrell R Fisher
1 reference
20 February 2007
1 reference
25
1 reference
11
1 reference
1396-1402
1 reference
Identifiers
1 reference